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Background: PHIRE (Public Health Innovation and Research in Europe) was developed for the national member
associations and individual researchers of the European Public Health Association (EUPHA) to engage collectively
with the health research agenda in Europe. It was co-funded by the European Commission’s Directorate for Health
and Consumers within the EU Health Programme. It was coordinated by EUPHA in a partnership of eight organ-
izations. This article introduces the Supplement in the European Journal of Public Health presenting the results of
PHIRE.Methods: PHIRE used mixed methods to collect data across 30 European countries (European Union 27 plus
Iceland, Norway and Switzerland). Seven thematic Sections of EUPHA identified eight cross-national public health
innovation projects, and Country Informants to report on national uptake and impact of these innovations. Public
health was considered broadly—health determinants and interventions, health services and practice. Through
EUPHA’s member national public health associations, and by direct country contacts, PHIRE described country
public health research strategies and structures, reviewed calls and programmes for research in 1 year and
organized stakeholder workshops. PHIRE was reported to the European Commission, and the component
reports placed on the EUPHA web page. A draft of the Final Summary Report was sent by email for
commentary by selected experts. Results: PHIRE data from the work packages were organized into eight
themes for the Supplement. Through the EUPHA thematic Sections, experts described the uptake and impact of
eight innovation projects from the EU Health Programme. National reports indicated a positive impact of the
innovations in public health ‘markets’. Through national public health associations, 75 programmes and calls for
public health research were found for 2010, but systems are not comparable and nor is information exchanged or
coordinated. Only a few countries have public health research strategies. Having competitive research funding
through Ministries of Health is potentially beneficial. There is limited contact between national and European
public health research programmes and calls. Experts who were sent the draft PHIRE Summary Report gave
generally positive responses on the validity and usefulness of the results. Dissemination has been achieved
through meetings during the study and by electronic means thereafter. Conclusion: PHIRE has increased
knowledge about public health innovation at national and European levels. Strengthening the public health
research system, and demonstrating innovation in public health markets will maximize benefits to Europe’s
citizens.
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PHIRE (Public Health Innovation and Research in Europe) wasdeveloped as a collaborative study working through the European
Public Health Association (EUPHA) to identify the uptake of public
health innovations and assess public health research systems in
European countries.1 The results of PHIRE are reported in this
Supplement of the European Journal of Public Health. This
Introduction describes the following articles and the responses of
experts to PHIRE.
Introduction
At the tenth annual scientific meeting of EUPHA, held in Dresden in
2002, a plenary discussion2 debated the lack of public health research
within the European Union’s Sixth Framework Research Programme
(2002–2006). Among the speakers, Hans Stein, who for many years
was a spokesperson for the German Ministry of Health at European
level and advocate for European public health research, described
the complex development of the European research programmes,3
which are led by the European Commission, controlled by polit-
icians (in the European Council and European Parliament) and
influenced by a wide range of stakeholders. Public health
scientists, Stein proposed, should seek to be more influential in
this process, both at national and European levels.
The European Commission’s Sixth Framework Research
Programme (2002–2006), in support of human genome research,
linked medical research together as ‘Life sciences, genomics and
bio-technology for health’.4 In a ‘cross-cutting’ theme, however,
‘Research for Policy Support’, a call was made in 2004 for a
Support Action on public health research.5 SPHERE6
(Strengthening Public Health Research in Europe), the successful
consortium of 17 partners, was led by the UK Faculty of Public
Health, with University College London and EUPHA. SPHERE
reviewed public health research at European level and in four
European neighbourhood countries, and made bibliometric studies
by country of six areas of public health research—health promotion,
health services, environmental health, genetic epidemiology,
infectious disease control and health management.7 These showed
a 10-fold range in publication rates across EU countries.8
Because of the situation identified in the new EU member
states, partners from SPHERE followed-up with a proposal to the
Seventh Framework Programme’s Science in Society call. STEPS
(Strengthening Engagement in Public Health Research9) addressed
the contribution of civil society organizations to health research in
these 12 countries.10 Methods developed in the study were
workshops for public health research stakeholders,11 interviews
with respondents in European-level health organizations12 and
systematic description of national health research systems.13 STEPS
showed that civil society organizations have a strong interest in
research—providing evidence for practice, and inclusion of local
people in creation of knowledge. The new EU member states also
received substantial funding for research through the European
Structural Funds, although this rarely appeared to reach public
health research.14
The European Commission’s own health research programme
within the Seventh Framework Research Programme was found to
spend <5% of the total on public health research: almost all was for
biomedical, clinical and pharmaceuticals research.15 However,
member states together support research to a much larger total
than EU funding.10
In 2008, as part of organizational development, EUPHA estab-
lished four pillars, including one for Research, to increase under-
standing of national public health research systems and impacts.
While the European Commission’s Directorate for Research and
Innovation made no further call for work on public health
research, PHIRE was successfully proposed in the 2009 Health
Programme of the Directorate for Health and Consumers.16
Process
A major theme of the European Union strategy for the next admin-
istrative and financial cycle (2014–2020) is the belief that research
contributes to economic and social development through innov-
ation.17,18 Emphasis has been put on support for industry, particu-
larly smaller companies, and in the health field, this is supported by
the network of health research national contact points (previously
SMEs-Go-Health, now titled Fit-for-Health19). STEPS had shown
the importance of civil society organizations engaging in the
research agenda,9 and innovation within the public service
sectors.20 PHIRE therefore addressed both innovation and
research. However, public health innovations draw on a range of
knowledge and practice, and do not develop simply from a single
research project. PHIRE chose to study how several differing innov-
ations were taken up at national level, and to look in parallel at
national systems for generating public health research.
The proposal submitted for PHIRE was for 3 years, with partners
from different regions of the EU. EUPHA provided the administra-
tion and the UK Faculty provided technical leadership. The proposal
required 40% of funds to be contributed by partners, and a
maximum 60% co-funding from the European Commission. At
the Health Programme evaluation, the Commission accepted the
proposal, but with a budget reduction by one quarter of the total
proposed. To maintain the study, the Consortium regretfully
reduced the project length to 30 months, reduced funding for the
national public health association members of EUPHA, and joined
the collection of country information under the four regional
partners, each managing data from seven countries.
PHIRE was constituted with eight partners and seven work
packages. The structure was designed to promote engagement
between partners and EUPHA. There were two phases, with
reporting to the funder at the half-way stage. The final ‘deliverables’
of PHIRE—the Work Package reports, Country reports and Final
Summary Report—were placed on the PHIRE web page of EUPHA.21
In Work Package 7, PHIRE partners prepared and agreed a draft
Summary Report21 in the 1-3-25 format recommended for optimum
communication of healthcare research results.22 To know the per-
ceptions of public health scientists to our work, and inform them of
the work, the draft Summary Report was emailed, with two short
questions, to 130 experts known to be interested in European public
health research across all 30 European countries (range 1–10 per
country) and to international bodies (including the European
Commission). The letter asked respectively about the perceived
validity and usefulness of results. There were 38 replies from 20
countries, with 33 (25% of sample) giving comments in enough
detail to use.
For dissemination to academic audiences, and contributing to the
health research literature, PHIRE results are presented as thematic
articles in this Supplement.23 The standard scientific format of intro-
duction, methods, results and conclusions is used. The authorship of
the articles relates to the broad leadership of the topic within the
PHIRE partnership, and the contribution in reports. The original
material can be found on the PHIRE web page www.eupha.org/phire.
The Supplement
The present article, ‘Public health innovation and research in Europe:
introduction to the Supplement’,1 provides a history of the study and
sets out the eight articles for publication in the European Journal of
Public Health Supplement. A strong feature of PHIRE was working
through members of the EUPHA, which provided links by expert field
and European country. Although there are limitations in the extent
and completeness of the data, the majority of experts replying to a
consultation on the draft PHIRE Summary Report confirmed both
that results appeared valid and useful.
The second article in the Supplement ‘PHIRE (public health
innovation and research in Europe): methods, activities and assess-
ment’24 describes the multi-methods approach needed to collect
descriptive data from a range of informants across different
national systems. Qualitative survey analysis must collect sufficiently
rich information while also being able to summarize it. Thematic
Section Presidents of EUPHA chose health innovation projects
supported by the European Commission, and Country Informants
reported on their uptake and impact through an on-line question-
naire. National public health associations (EUPHA members)
reviewed information on the health research systems of their
countries, held national stakeholder workshops and provided
reports. These methods underpin the results in further articles.
The third article ‘Civil society engagement in innovation and
research through the European Public Health Association’25
addresses the study design of engaging European public health
scientists and practitioners through EUPHA. The thematic
interests of the EUPHA Sections matched the public health topics
within European Commission’s Health Programme, and Section
members contributed as expert Country Informants. EUPHA has
member associations in almost all EU countries, and in a majority
of countries the associations contributed to PHIRE—although
limited co-finance from PHIRE was a reservation for some associ-
ations. The national reports, though varied in completeness, gave
important material for the articles in the Supplement. PHIRE
demonstrated a basis for further capacity building and data
collection through EUPHA.
The fourth and fifth articles are concerned with innovation. While
innovation follows research, PHIRE was able to make a longitudinal
study of the uptake and impact of public health innovations that
were funded for demonstration and dissemination by the European
Union’s Public Health Programme in 2003–2005. The fourth article
‘Tracking uptake of innovations from the European Union’s Public
Health Programme’26 reports the perceptions of 108 Country
Informants (CIs) on the impact and uptake of innovations. Seven
of the eight innovation projects were considered by at least 70% of
the CIs to be of high or moderate relevance. Some projects had
impacts within the policy cycle in particular countries. Some
projects had greater visibility at local level. The results emphasize
the need to track and examine the uptake of public health innov-
ations across Europe.
The fifth article ‘Impact of innovations in national public health
markets in Europe’27 was based on the PHIRE reports from 11
countries. Innovation is of increasing economic interest in
European countries. PHIRE identified 35 descriptions of impacts
in national public health markets, but also found 10 descriptions
of limited uptake where there were competing existing practices.
This analysis encourages further investigation of how public
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innovations develop and disseminate across Europe and within
countries. In comparison with pharmaceuticals, for example, under-
standing of the characterization, marketing and implementation of
innovations in public health is at an early stage.
The sixth article ‘Programmes and calls for public health research
in European countries’,28 drawing on work in the first phase of
PHIRE, provides a ‘snapshot’ of public health research
programmes and calls in 2010. This was a time of public budget
cuts in Europe—in several countries, particularly in Eastern Europe,
there were no calls or programmes recorded for that year. For some
countries, it was difficult to isolate public health research
programmes and calls within broader health research, but in
others there were clearly defined programmes and calls, including
in relation to the major diseases. The work showed the need to
develop classifications and databases for public health research
databases, to increase exchange between countries and to research
more directly at key public health questions.
The seventh and eighth articles, drawing from the national
workshop reports, supplemented with internet searches, describe
national public health research strategies and structures, respectively.
The seventh article, ‘Strategies for public health research in
European countries’29 shows that, although all European countries
undertake health research, only a minority have health research
strategies and still fewer relate these to public health research
priorities. In many countries, there is only weak communication
and collaboration between Ministries of Health and other health
research stakeholders.
The eighth article ‘Competitive funding and structures for public
health research in European countries’30 draws together PHIRE data
on national health research systems. Funding for ‘discovery’ and
‘intervention’ health research through Ministries of Science is
mainly for biomedicine. Public health research appears stronger in
countries with funding from the Ministry of Health and independent
organizations. However, financial information at national level for
systematic comparisons is weak, and the proportion of funds going
to research directly through universities rather than competitively, is
unknown. The balance between biomedical and public health
research will also be a significant issue for Horizon 2020.
The final article ‘National action for European public health
research’31 draws the findings from PHIRE together at European
level. PHIRE has explored national innovation and research
programmes and systems where there has previously been little
information: PHIRE is also concerned through EUPHA to address
the European level. Only a minority of Ministries of Health had
contributed to developing Horizon 2020, and Ministries of Science
have not presented a vision of collective public health research. Yet
public health knowledge in one country has applications for other
countries. Cross-national studies offer both stronger and faster
results, and also provide variety of social and political contexts for
understanding both health determinants and the impacts of
interventions.
Results of the Retrospective Assessment
In writing the final materials, a PHIRE draft Summary Report22 was
written and circulated to 130 experts across the 30 European
countries. Replies were gained from 33 respondents to two
questions. Question 1 asked: ‘From your perspective, do the
findings of PHIRE seem valid?’ There were 26 respondents
answering yes to this question, and most respondents provided
fuller replies; the most common reservation expressed was the sub-
jectivity of the viewpoints recorded by PHIRE. Question 2 asked:
‘Are these useful recommendations for European public health
innovation and research?’ Twenty-three respondents said ‘yes’ or
equivalent to this question, and several described the usefulness of
the results, but some expressed reservations and uncertainty. The full
responses are found at the PHIRE web page.
The PHIRE Summary Report21,22 made three sets of
recommendations:
 European countries should identify public health research within
national health research systems, clarify and improve levels of
funding, and align research calls and programmes with national
health plans.
PHIRE found insufficient information on public health research
within European countries. Strengthening the country systems and
giving voice to the public health science is crucial for the develop-
ment of evidence-based practice and policy.
 European countries should promote innovation and research
through health and civil society organizations working in the
public interest and taking the place of commercial organizations
elsewhere in the economy.
Both European countries and the European Union are giving
emphasis to linking research and innovation with industry and the
commercial sector. Public health research creates knowledge that is
non-commercial but vital for the welfare of society. PHIRE urges
that research and innovation funding should go to support not-for-
profit public services and civil society organizations as much as for-
profit ‘small and medium enterprises’ (SMEs).
 European countries, within Horizon 2020, should prioritize health
promotion, health care and health determinants research and
innovation, and coordination mechanisms including through the
European Research Council, Research Infrastructures, ERA-nets,
Joint Programming and national-level Structural Funds.
Horizon 2020 has a set out a large field of topics for health research,
and has instruments and funds for coordination of research between
countries, and across academic disciplines. Member states, through
Horizon 2020 programme committees, should use these instruments
for building cross-national public health research.
Discussion
An overarching theme from PHIRE has been the need for better
information and coordination. The European research programme
for 2007–2013 developed several mechanisms for strengthening the
European Research Area, including national ministry networks
(ERA-nets), Joint Programming (sharing national thematic
programmes) and Infrastructures (developing shared facilities and
databases)32: none of this was directed towards public health.
It is unclear to the public health research community where
decisions are made within the Research Directorate. The
Programme Committee for Health Research meets twice yearly
with representatives from each member state, but there is little
feedback or national consultation from its members. Inter-service
communication between the European Commission Research
Directorate and the Directorate for Health and Consumers is
unclear, beyond the guideline that the Research Directorate
supports research, and the Health Directorate supports demonstra-
tion and implementation. STEPS and PHIRE were not funded by the
Seventh Framework Health Research Programme, and therefore do
not show in the report on public health research supported by the
European Commission.33
The European Union has given emphasis to participation of
industry in research and innovation.34 Health services are around
10% of economic activity across European countries, and continue
to grow. The pharmaceutical and medical devices industries supply
the health sector, and are significant investors in research. But the
objectives of public health research at population level, for both
discovery and interventions, are different—towards prevention,
health promotion and the efficiency and effectiveness of health
systems. European and national policies for health research and
innovation must give more emphasis to research for public goods
as well as patents, and more interest in delivering health sector
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improvements through public and not-for-profit services. In
Horizon 2020, the Directorate of Research’s project ‘Fit-for-
Health’19 could promote assessment of public health innovations
across countries and feed this knowledge into the European public
health section of the research programme.35
A Work Package on dissemination is mandatory within the
template of the European Commission Directorate for Health and
Consumers Health Programme. PHIRE undertook dissemination
during the project by several means—the EUPHA newsletter,
emails, website, database and the conference. The full materials of
PHIRE, including the database of country reports, are placed on the
EUPHA web pages.21 The Summary Report22 and this Supplement1
have been created to enable dissemination of the results from
PHIRE. The European Agency for Health and Consumers, which
commissions and monitors the EU Health Programme projects, is
working with EUPHA on a day pre-meeting at the November 2013
European Public Health conference. This Supplement of the
European Journal of Public Health will be presented there, and
then available for dissemination through electronic pages of the
European Journal of Public Health.
Conclusion
Through EUPHA and its partners, PHIRE has identified important
aspects of the European public health research system, particularly at
national level. Given the importance of creating the evidence base for
public health policy and practice, and extending the boundaries of
discovery in population sciences, researchers, civil society organiza-
tions, practitioners, policy makers and research commissioners
should work together to maximize returns from health research
programmes. These links must be within countries, across
countries and together with European programmes.
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